Individual generic drug information
Extracted information for Lutropin alfa only.
Treatment of infertility in women with proven hypopituitarism or who have not responded to clomifene (in conjunction with follicle-stimulating hormone) | Superovulation treatment for assisted conception (such as in vitro fertilisation) (in conjunction with follicle- stimulating hormone) ▶BY SUBCUTANEOUS INJECTION ▶Adult (female): Adjusted according to response.
Source page 809
Mammary carcinoma. ovarian carcinoma. ovarian enlargement or cyst (unless caused by polycystic ovarian disease). tumours of hypothalamus. tumours of pituitary. undiagnosed vaginal bleeding. uterine carcinoma
Source page 809
Acute porphyrias p. 1120
Source page 809
Extracted information for Lutropin alfa only.
▶Common or very common Breast pain. diarrhoea. gastrointestinal discomfort. headache. nausea. ovarian and fallopian tube disorders. pelvic pain. vomiting ▶Rare or very rare Thromboembolism
Source page 809
Extracted information for Lutropin alfa only.
There can be variation in the licensing of different medicines containing the same drug. Powder and solvent for solution for injection ▶Luveris (Merck Serono Ltd) Lutropin alfa 75 unit Luveris 75unit powder and solvent for solution for injection vials | 1 vial P £31.38
Source page 809
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
Adjusted according to response.
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 809
